Literature DB >> 10610445

Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma.

K Peris, M C Fargnoli, S Chimenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10610445     DOI： 10.1056/NEJM199912023412312

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.

Authors:  Jean Y Tang; Albert S Chiou; Julian M Mackay-Wiggan; Michelle Aszterbaum; Anita M Chanana; Wayne Lee; Joselyn A Lindgren; Maria Acosta Raphael; Bobbye J Thompson; David R Bickers; Ervin H Epstein
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-17

Review 2.  Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies.

Authors:  Julien Lanoue; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01

Review 3.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

Review 4.  [Precancerous and early invasive carcinomas: non-surgical treatment of head and facial skin].

Authors:  E Haneke
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

Review 5.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Pathogenesis of Keratinocyte Carcinomas and the Therapeutic Potential of Medicinal Plants and Phytochemicals.

Authors:  Andrea Jess Josiah; Danielle Twilley; Sreejarani Kesavan Pillai; Suprakas Sinha Ray; Namrita Lall
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

7.  Bowenoid papulosis of the genitalia successfully treated with topical tazarotene: a report of two cases.

Authors:  Veeranna Shastry; Jayadev Betkerur
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

8.  A phase 1 study of tazarotene in adults with advanced cancer.

Authors:  P H Jones; R D Burnett; I Fainaru; P Nadolny; P Walker; Z Yu; D Tang-Liu; T S Ganesan; D C Talbot; A L Harris; G J S Rustin
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.